Infinity Pharmaceuticals | INFI - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Grifols EUR 680.58M 846.11K 2025-12
Incyte USD 199.95M 1.49M 2026-03
Infinity Pharmaceuticals USD 90K 1000 2023-06
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
J&J USD 2.41B 1.74M 2025-12
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 13M 2026-03
Plus Therapeutics USD 138.68M 7.07M 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
TG Therapeutics USD 155.31M 95K 2025-12